|
Bafna Pharmaceuticals Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
339.21 Cr.
|
P/BV
|
4.00
|
Book Value (Rs.)
|
35.85
|
|
52 Week High/Low (Rs.)
|
202/69
|
FV/ML
|
10/1
|
P/E(X)
|
81.70
|
|
Bookclosure
|
25/09/2024
|
EPS (Rs.)
|
1.76
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 29.34 |
| Total Income From Operations | 29.34 |
| | |
| EXPENDITURE | |
| Consumption of Raw Materials | 23.84 |
| Purchase of Traded Goods | 0.02 |
| Increase/Decrease in Stocks | -1.52 |
| Employees Cost | 7.17 |
| Depreciation | 2.74 |
| Other Expenses | 2.85 |
| Total Expenses | 35.10 |
| | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -5.76 |
| Other Income | 0.93 |
| P/L Before Interest, Excpt. Items & Tax | -4.84 |
| Interest | 0.07 |
| P/L Before Exceptional Items & Tax | -4.91 |
| Exceptional Items | -20.99 |
| P/L Before Tax | -25.89 |
| Tax | -1.58 |
| P/L After Tax from Ordinary Activities | -24.32 |
| Net Profit/Loss For the Period | -24.32 |
| Net P/L After Minority Interest & Share Of Associates | -24.32 |
| | |
| Equity Share Capital | 23.66 |
| EPS Before Extra Ordinary * | |
| Basic EPS (Rs.) | -148.41 |
| Diluted EPS (Rs.) | -148.41 |
| EPS After Extra Ordinary * | |
| Basic EPS (Rs.) | -148.41 |
| Diluted EPS (Rs.) | -148.41 |
| | |
| PBITOE Margin (%) | -19.64 |
| PBTE Margin (%) | -16.72 |
| PBT Margin (%) | -88.25 |
| PAT Margin (%) | -82.87 |
| PAT After MI And SOA Margin (%) | -82.87 |
